comparemela.com
Latest Breaking News On - Smart medical industry - Page 1 : comparemela.com
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
KR-HT5 is based on Akoya’s PhenoImager® HT PlatformMARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 Akoya Biosciences, Inc. , The Spatial Biology Company®, and Shanghai KR Pharmtech, a.
China
Shanghai
Xuzhou
Jiangsu
Chinese
Akoya-biosciences
Brian-mckelligon
Rui-zhang
Akoya-bioscience
Priyam-shah
Akoya-phenoimager
Spatial-biology-company
vimarsana © 2020. All Rights Reserved.